Rani Therapeutics Holdings Stock Price History
RANI Stock | USD 1.55 0.05 3.33% |
If you're considering investing in Rani Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rani Therapeutics stands at 1.55, as last reported on the 24th of March, with the highest price reaching 1.55 and the lowest price hitting 1.46 during the day. Rani Therapeutics appears to be dangerous, given 3 months investment horizon. Rani Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0528, which implies the firm had a 0.0528 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Rani Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Rani Therapeutics' Risk Adjusted Performance of 0.0547, semi deviation of 3.85, and Coefficient Of Variation of 1910.27 to confirm if our risk estimates are consistent with your expectations.
Rani Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Rani |
Sharpe Ratio = 0.0528
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | RANI | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.18 actual daily | 46 54% of assets are more volatile |
Expected Return
0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Rani Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rani Therapeutics by adding it to a well-diversified portfolio.
Rani Therapeutics Stock Price History Chart
There are several ways to analyze Rani Stock price data. The simplest method is using a basic Rani candlestick price chart, which shows Rani Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 14, 2025 | 1.85 |
Lowest Price | January 10, 2025 | 1.25 |
Rani Therapeutics March 24, 2025 Stock Price Synopsis
Various analyses of Rani Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Rani Stock. It can be used to describe the percentage change in the price of Rani Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Rani Stock.Rani Therapeutics Price Action Indicator | 0.07 | |
Rani Therapeutics Price Rate Of Daily Change | 1.03 | |
Rani Therapeutics Price Daily Balance Of Power | 0.56 |
Rani Therapeutics March 24, 2025 Stock Price Analysis
Rani Stock Price History Data
The price series of Rani Therapeutics for the period between Tue, Dec 24, 2024 and Mon, Mar 24, 2025 has a statistical range of 0.6 with a coefficient of variation of 8.48. The price distribution for the period has arithmetic mean of 1.48. The median price for the last 90 days is 1.47.Open | High | Low | Close | Volume | ||
03/24/2025 | 1.46 | 1.55 | 1.46 | 1.55 | ||
03/21/2025 | 1.46 | 1.55 | 1.46 | 1.55 | 81,505 | |
03/20/2025 | 1.49 | 1.53 | 1.48 | 1.50 | 48,111 | |
03/19/2025 | 1.50 | 1.50 | 1.45 | 1.47 | 108,302 | |
03/18/2025 | 1.54 | 1.54 | 1.48 | 1.50 | 48,528 | |
03/17/2025 | 1.52 | 1.55 | 1.51 | 1.54 | 102,957 | |
03/14/2025 | 1.47 | 1.54 | 1.46 | 1.51 | 58,235 | |
03/13/2025 | 1.54 | 1.54 | 1.45 | 1.46 | 61,891 | |
03/12/2025 | 1.43 | 1.56 | 1.41 | 1.53 | 141,789 | |
03/11/2025 | 1.48 | 1.49 | 1.41 | 1.46 | 180,288 | |
03/10/2025 | 1.51 | 1.55 | 1.46 | 1.48 | 140,029 | |
03/07/2025 | 1.58 | 1.59 | 1.51 | 1.56 | 117,004 | |
03/06/2025 | 1.54 | 1.58 | 1.49 | 1.58 | 170,267 | |
03/05/2025 | 1.45 | 1.54 | 1.43 | 1.54 | 146,229 | |
03/04/2025 | 1.46 | 1.46 | 1.41 | 1.43 | 158,231 | |
03/03/2025 | 1.54 | 1.54 | 1.41 | 1.47 | 462,804 | |
02/28/2025 | 1.50 | 1.53 | 1.47 | 1.53 | 190,695 | |
02/27/2025 | 1.58 | 1.58 | 1.49 | 1.50 | 206,217 | |
02/26/2025 | 1.45 | 1.56 | 1.45 | 1.54 | 158,823 | |
02/25/2025 | 1.54 | 1.54 | 1.44 | 1.47 | 330,824 | |
02/24/2025 | 1.64 | 1.65 | 1.50 | 1.52 | 418,173 | |
02/21/2025 | 1.76 | 1.76 | 1.65 | 1.66 | 227,811 | |
02/20/2025 | 1.67 | 1.77 | 1.59 | 1.73 | 346,779 | |
02/19/2025 | 1.74 | 1.80 | 1.65 | 1.73 | 334,152 | |
02/18/2025 | 1.84 | 1.85 | 1.71 | 1.75 | 468,336 | |
02/14/2025 | 1.87 | 1.90 | 1.76 | 1.85 | 667,131 | |
02/13/2025 | 1.81 | 1.89 | 1.72 | 1.84 | 1,425,351 | |
02/12/2025 | 1.46 | 1.71 | 1.42 | 1.69 | 1,510,371 | |
02/11/2025 | 1.42 | 1.48 | 1.35 | 1.41 | 693,869 | |
02/10/2025 | 1.50 | 1.55 | 1.41 | 1.42 | 1,082,203 | |
02/07/2025 | 1.60 | 1.65 | 1.50 | 1.52 | 2,193,757 | |
02/06/2025 | 1.76 | 1.82 | 1.50 | 1.65 | 25,091,133 | |
02/05/2025 | 1.37 | 1.45 | 1.36 | 1.44 | 9,843,164 | |
02/04/2025 | 1.35 | 1.40 | 1.35 | 1.37 | 101,249 | |
02/03/2025 | 1.35 | 1.39 | 1.35 | 1.36 | 110,103 | |
01/31/2025 | 1.42 | 1.43 | 1.38 | 1.39 | 68,105 | |
01/30/2025 | 1.40 | 1.41 | 1.35 | 1.38 | 207,591 | |
01/29/2025 | 1.39 | 1.47 | 1.37 | 1.39 | 89,399 | |
01/28/2025 | 1.44 | 1.45 | 1.35 | 1.40 | 115,253 | |
01/27/2025 | 1.48 | 1.50 | 1.40 | 1.43 | 86,819 | |
01/24/2025 | 1.49 | 1.52 | 1.45 | 1.50 | 113,903 | |
01/23/2025 | 1.50 | 1.52 | 1.45 | 1.48 | 203,696 | |
01/22/2025 | 1.40 | 1.50 | 1.37 | 1.49 | 239,867 | |
01/21/2025 | 1.33 | 1.49 | 1.33 | 1.41 | 304,788 | |
01/17/2025 | 1.32 | 1.35 | 1.31 | 1.31 | 121,282 | |
01/16/2025 | 1.31 | 1.34 | 1.27 | 1.32 | 171,811 | |
01/15/2025 | 1.30 | 1.32 | 1.27 | 1.31 | 154,072 | |
01/14/2025 | 1.30 | 1.32 | 1.26 | 1.28 | 180,293 | |
01/13/2025 | 1.27 | 1.31 | 1.24 | 1.30 | 266,550 | |
01/10/2025 | 1.39 | 1.39 | 1.25 | 1.25 | 557,598 | |
01/08/2025 | 1.42 | 1.48 | 1.34 | 1.36 | 437,784 | |
01/07/2025 | 1.50 | 1.54 | 1.42 | 1.43 | 181,953 | |
01/06/2025 | 1.58 | 1.60 | 1.46 | 1.49 | 376,259 | |
01/03/2025 | 1.45 | 1.61 | 1.45 | 1.53 | 525,099 | |
01/02/2025 | 1.38 | 1.48 | 1.38 | 1.46 | 384,852 | |
12/31/2024 | 1.50 | 1.50 | 1.36 | 1.37 | 597,697 | |
12/30/2024 | 1.38 | 1.55 | 1.35 | 1.48 | 550,105 | |
12/27/2024 | 1.37 | 1.50 | 1.36 | 1.42 | 525,993 | |
12/26/2024 | 1.40 | 1.45 | 1.37 | 1.42 | 490,421 | |
12/24/2024 | 1.40 | 1.44 | 1.36 | 1.42 | 223,632 | |
12/23/2024 | 1.40 | 1.52 | 1.37 | 1.42 | 492,377 |
About Rani Therapeutics Stock history
Rani Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rani is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rani Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rani Therapeutics stock prices may prove useful in developing a viable investing in Rani Therapeutics
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company was incorporated in 2012 and is headquartered in San Jose, California. Rani Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 114 people.
Rani Therapeutics Stock Technical Analysis
Rani Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
Rani Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rani Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Rani Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rani to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0547 | |||
Jensen Alpha | 0.306 | |||
Total Risk Alpha | 0.6489 | |||
Sortino Ratio | 0.0764 | |||
Treynor Ratio | 0.3694 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Rani Stock analysis
When running Rani Therapeutics' price analysis, check to measure Rani Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rani Therapeutics is operating at the current time. Most of Rani Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rani Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rani Therapeutics' price. Additionally, you may evaluate how the addition of Rani Therapeutics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |